Lexicon Pharmaceuticals Inc (LXRX) — Tangible Net Worth Ratio
Lexicon Pharmaceuticals Inc (LXRX) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($202.86 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Lexicon Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Lexicon Pharmaceuticals Inc Tangible Net Worth Ratio (1999–2025)
This chart shows how Lexicon Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 26 annual periods from 1999 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $202.86 Million with intangible assets of $0.00 USD. See Lexicon Pharmaceuticals Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Lexicon Pharmaceuticals Inc (1999–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Lexicon Pharmaceuticals Inc from 1999 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Lexicon Pharmaceuticals Inc.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $107.54 Million | $0.00 | $184.99 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $145.95 Million | $0.00 | $298.42 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $93.11 Million | $0.00 | $229.43 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $117.12 Million | $0.00 | $194.30 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $113.59 Million | $0.00 | $136.91 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $156.37 Million | $0.00 | $203.79 Million | ▲ +16.8 pp |
| 2019 | 83.2% | $117.10 Million | $19.72 Million | $417.71 Million | ▲ +82.7 pp |
| 2017 | 0.4% | $52.10 Million | $51.88 Million | $436.54 Million | ▼ -65.7 pp |
| 2016 | 66.1% | $157.40 Million | $53.36 Million | $475.62 Million | ▼ -15.2 pp |
| 2015 | 81.3% | $285.85 Million | $53.36 Million | $654.83 Million | ▲ +0.1 pp |
| 2014 | 81.2% | $284.02 Million | $53.36 Million | $471.38 Million | ▲ +12.7 pp |
| 2013 | 68.5% | $170.16 Million | $53.56 Million | $274.16 Million | ▼ -11.4 pp |
| 2012 | 79.9% | $266.68 Million | $53.56 Million | $371.78 Million | ▼ -2.1 pp |
| 2011 | 82.0% | $297.57 Million | $53.56 Million | $430.51 Million | ▲ +3.7 pp |
| 2010 | 78.3% | $247.02 Million | $53.56 Million | $366.88 Million | ▼ -5.9 pp |
| 2009 | 84.2% | $163.50 Million | $25.80 Million | $257.76 Million | ▼ -2.6 pp |
| 2008 | 86.8% | $195.83 Million | $25.80 Million | $261.51 Million | ▼ -4.2 pp |
| 2007 | 91.0% | $286.57 Million | $25.80 Million | $369.30 Million | ▲ +21.2 pp |
| 2006 | 69.8% | $85.50 Million | $25.80 Million | $190.27 Million | ▲ +0.6 pp |
| 2005 | 69.2% | $85.80 Million | $26.44 Million | $218.71 Million | ▼ -8.1 pp |
| 2004 | 77.3% | $121.59 Million | $27.64 Million | $211.98 Million | ▼ -5.4 pp |
| 2003 | 82.7% | $166.22 Million | $28.84 Million | $284.20 Million | ▲ +0.3 pp |
| 2002 | 82.3% | $169.90 Million | $30.04 Million | $201.77 Million | ▼ -15.2 pp |
| 2001 | 97.5% | $218.37 Million | $5.44 Million | $239.99 Million | ▼ -2.5 pp |
| 2000 | 100.0% | $207.63 Million | $0.00 | $220.69 Million | ▲ +0.0 pp |
| 1999 | 100.0% | $8.20 Million | $0.00 | $22.30 Million | — |